Resynergi Secures $18 Million in Series B Extension Led by Taranis to Accelerate Plastic Recycling Innovation

Gold nanoparticles effectively deliver CRISPR to mouse models of DMD | Fierce Biotech

CRISPR-Cas9 has emerged in recent years as a promising weapon against genetic disease.

Investor Connect – Deepak Gupta of Blue Bear Ventures